Digestive and metabolic diseases

S 1805: Promoting Access to Diabetic Shoes Act

Promoting Access to Diabetic Shoes Act

This bill allows a nurse practitioner or physician assistant to fulfill documentation requirements for coverage, under Medicare, of special shoes for diabetic individuals. Under current law, such requirements may be satisfied only by a physician.

Sponsors

Susan Collins (R) ME

Cosponsors

Jeanne Shaheen (D) NH

Introduced on
Monday, May 19th, 2025

Subjects
Digestive and metabolic diseases, Health information and medical records, Health personnel, Health technology, devices, supplies, Medicare

HR 1616: Promoting Access to Diabetic Shoes Act

Promoting Access to Diabetic Shoes Act

Sponsors

Darin LaHood (R) IL

Cosponsors

Nanette Barragu00e1n (D) CA

Introduced on
Wednesday, February 26th, 2025

Subjects
Digestive and metabolic diseases, Health information and medical records, Health personnel, Health technology, devices, supplies, Medicare

HR 1518: New Era of Preventing End-Stage Kidney Disease Act

New Era of Preventing End-Stage Kidney Disease Act

This bill establishes regional centers of excellence, postgraduate fellowships, and training for health professionals relating to the diagnosis and treatment of rare kidney disease. It also requires the Department of Health and Human Services (HHS) to conduct various studies on rare kidney disease.

Specifically, it authorizes the National Institute of Diabetes and Digestive and Kidney Diseases to award funding to public and private nonprofit entities for establishing regional centers of excellence that will increase public awareness, conduct research, and develop resources for diagnosing and treating rare kidney diseases. A center may receive such funding for up to five years, unless extended by the institute.

The bill also requires health professions schools receiving a grant from the Health Resources and Services Administration (HRSA) Centers of Excellence program to award fellowships for training on preventing, diagnosing, and treating rare kidney disease in disproportionately impacted populations.

Also, the bill expands the priorities of HRSA’s Primary Care Training and Enhancement program to include training for health care workers to care for individuals with kidney disease.

Additionally, HHS must conduct several studies and report to Congress on topics such as treating rare kidney disease in disproportionately affected populations, eliminating the need for dialysis or kidney transplants, and increasing public awareness of rare kidney disease.

Sponsors

Gus Bilirakis (R) FL

Cosponsors

Terri Sewell (D) AL, Carol Miller (R) WV, Scott Peters (D) CA, Troy Balderson (R) OH, Paul Tonko (D) NY, Bradley Schneider (D) IL, Danny Davis (D) IL

Introduced on
Monday, February 24th, 2025

Subjects
Congressional oversight, Digestive and metabolic diseases, Genetics, Government studies and investigations, Health care coverage and access, Health programs administration and funding, Health promotion and preventive care, Medical education, Medical research, Medical tests and diagnostic methods, Research administration and funding

HR 1523: PREVENT DIABETES Act

Promoting Responsible and Effective Virtual Experiences through Novel Technology to Deliver Improved Access and Better Engagement with Tested and Evidence-based Strategies Act or the PREVENT DIABETES Act

This bill allows health care entities to provide virtual services under the Medicare Diabetes Prevention Program for an additional three years.

The Medicare Diabetes Prevention Program offers Medicare beneficiaries who are at risk of developing Type 2 diabetes specialized training and education regarding diet, exercise, and other behavioral changes. The Centers for Medicare & Medicaid Services issued temporary authorization for entities participating in the program to provide these services virtually until December 31, 2027.

The bill extends the authorization for virtual services until December 31, 2030.

Sponsors

Diana DeGette (D) CO

Cosponsors

Gus Bilirakis (R) FL, Jason Crow (D) CO, Kim Schrier (D) WA

Introduced on
Monday, February 24th, 2025

Subjects
Administrative law and regulatory procedures, Computers and information technology, Department of Health and Human Services, Digestive and metabolic diseases, Health care coverage and access, Health promotion and preventive care, Health technology, devices, supplies, Medicare

S 243: Radiation Exposure Compensation Reauthorization Act

Radiation Exposure Compensation Reauthorization Act

This bill reauthorizes and expands programs that compensate individuals who were exposed to radiation during certain nuclear testing or uranium mining and who subsequently developed medical conditions, including cancers.

Under current law, compensation is payable to individuals based on requirements including the (1) dates when exposure occurred, (2) duration of exposure, (3) type of exposure, and (4) resulting medical condition.

Among other changes to this program, the bill (1) extends the eligible dates when qualifying atmospheric exposure occurred, (2) authorizes compensation to individuals with combined work histories in uranium mining, (3) adds core drilling as an eligible mining occupation, and (4) increases the amount of compensation awarded to qualifying individuals.

The bill also expands this program to compensate individuals located in specified areas in Alaska, Kentucky, Missouri, and Tennessee associated with waste from the Manhattan Project and who subsequently developed specified types of cancer.

The bill extends until five years after this bill’s enactment the statute of limitations for the filing of claims.

The bill also expands eligibility under an existing occupational illness compensation program for former Department of Energy employees.

The bill also establishes a grant program for institutions of higher education to study the epidemiological impacts of uranium mining and milling among individuals without occupational exposure.

The bill directs the Government Accountability Office to study and report to Congress on the unmet medical benefits coverage for individuals who were exposed to radiation in atmospheric nuclear tests conducted by the federal government.

Sponsors

Josh Hawley (R) MO

Cosponsors

Ben Lujan (D) NM, Eric Schmitt (R) MO, Martin Heinrich (D) NM, Mark Kelly (D) AZ, Mike Crapo (R) ID

Introduced on
Friday, January 24th, 2025

Subjects
Administrative law and regulatory procedures, Arizona, Cancer, Civil actions and liability, Colorado, Department of Justice, Digestive and metabolic diseases, Education programs funding, Environmental health, Government information and archives, Government liability, Government trust funds, Guam, Hazardous wastes and toxic substances, Health care costs and insurance, Higher education, Idaho, Medical research, Military history

HR 307: ARC Act of 2025

Amputation Reduction and Compassion Act of 2025 or the ARC Act of 2025

This bill provides for coverage of peripheral artery disease screening tests without cost-sharing under Medicare and Medicaid for certain at-risk individuals. It also requires the development of certain educational programs, a payment model, and Medicare quality measures to reduce amputations relating to such disease.

Sponsors

LaMonica McIver (D) NJ

Cosponsors

Jonathan Jackson (D) IL, Robin Kelly (D) IL

Introduced on
Thursday, January 9th, 2025

Subjects
Cardiovascular and respiratory health, Digestive and metabolic diseases, Education programs funding, Employee benefits and pensions, Health care costs and insurance, Health care coverage and access, Health care quality, Health programs administration and funding, Health promotion and preventive care, Health technology, devices, supplies, Home and outpatient care, Hospital care, Insurance industry and regulation, Medicaid, Medical tests and diagnostic methods, Medicare, Surgery and anesthesia

HR 124: Byron Nash Renal Medullary Carcinoma Awareness Act of 2023

Byron Nash Renal Medullary Carcinoma Awareness Act of 2023 [sic]

This bill allows states to receive federal payment under Medicaid for 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. (Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.)

Sponsors

Al Green (D) TX

Cosponsors

None

Introduced on
Friday, January 3rd, 2025

Subjects
Cancer, Digestive and metabolic diseases, Health promotion and preventive care, Medicaid

Nothing left to load.